Mycobacterium tuberculosis is an important global pathogen for which new drugs are urgently required. The ability of the organism to survive and multiply within macrophages may contribute to the lengthy treatment regimen with multiple drugs that are required to cure the infection. We screened the MyriaScreen II diversity library of 10. 000 compounds to identify novel inhibitors of M. https://www.roneverhart.com/Mara-s-Kaleidoscope/